RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.540
+0.040 (2.67%)
Jan 21, 2025, 4:00 PM EST - Market closed
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $36.94 million as of January 21, 2025. Its market cap has increased by 86.72% in one year.
Market Cap
36.94M
Enterprise Value
26.63M
1-Year Change
86.72%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $36.94M, a decrease of -46.19%. That is a compound annual growth rate of -16.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 35.98M | 16.28% |
| Dec 31, 2024 | 30.94M | 26.36% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |